TAxolcur llc

Founded in
2021
Market type
B2C
Fund to raise
1 - 5 Million USD
Funding stage
Series A
Website/App
Operation geo
West Berlin
Target gro roadmap

Founders

Paul H. Schwartz

CEO

download.jpg

Mewa Singh-Sandhu

COO

download.jpg

Michael R. Briggs

CSO

Problem addressing

NACO supported blood banks -- Indian Red cross (multiple locations), Lions, NTR Trust, Lifeline, Arpan etc.,

Company overview

It is proven that paclitaxel, the active medicine in TaxolCurTM, is an effective cancer therapy. It is an FDA approved therapeutic.
Until now, it has not been used in dogs because of side effects. We have solved this key issue with TaxolCur™